Biblio
2023
Xu C, Huang KKyon, Law JHao, Chua JShijia, Sheng T, Flores NM, Pizzi MPool, Okabe A, Tan ALay Keng, Zhu F, et al. Comprehensive molecular phenotyping of -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut. 2023.
2022
Ho SWei Ting, Sheng T, Xing M, Ooi WFong, Xu C, Sundar R, Huang KKyon, Li Z, Kumar V, Ramnarayanan K, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2022.
2020
Xing M, Ooi WFong, Tan J, Qamra A, Lee P-H, Li Z, Xu C, Padmanabhan N, Lim JQuan, Guo YAmanda, et al. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. J Clin Invest. 2020.
2015
Cutcutache I, Suzuki Y, Tan IBeehuat, Ramgopal S, Zhang S, Ramnarayanan K, Gan A, Lee HHong, Tay STing, Ooi A, et al. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas. Eur Urol. 2015.
Tan J, Ong CKiat, Lim WKhong, Ng CChuan Youn, Thike AAye, Ng LMoy, Rajasegaran V, Myint SSwe, Nagarajan S, Thangaraju S, et al. Genomic landscapes of breast fibroepithelial tumors. Nat Genet. 2015.
2014
Lim WKhong, Ong CKiat, Tan J, Thike AAye, Ng CChuan Youn, Rajasegaran V, Myint SSwe, Nagarajan S, Nasir NDiyana Md, McPherson JR, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014.
]